Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million for August 2020GlobeNewsWire • 09/09/20
Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation TrialGlobeNewsWire • 09/08/20
Pacira (PCRX) Up 4.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/05/20
Flexion Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare ConferenceGlobeNewsWire • 09/03/20
Flexion Therapeutics Announces Appointment of Liz Kwo, MD, to its Board of DirectorsGlobeNewsWire • 08/19/20
Pacira BioSciences's (PCRX) CEO David Stack on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business UpdateGlobeNewsWire • 08/06/20
Flexion Therapeutics (FLXN) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/05/20
Pacira BioSciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/05/20
Flexion Therapeutics Reports Second-Quarter 2020 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/05/20
Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & AnalgesiaGlobeNewsWire • 08/05/20
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric PatientsGlobeNewsWire • 08/04/20
Flexion Therapeutics to Report Second-Quarter 2020 Financial Results on August 5, 2020GlobeNewsWire • 07/30/20
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020GlobeNewsWire • 07/30/20
Will Flexion Therapeutics (FLXN) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/28/20
Flexion Therapeutics (FLXN) Is Up 9.84% in One Week: What You Should KnowZacks Investment Research • 07/23/20
Are Options Traders Betting on a Big Move in Flexion (FLXN) Stock?Zacks Investment Research • 07/15/20
Flexion Therapeutics Announces Preliminary Second-Quarter 2020 ZILRETTA® Net SalesGlobeNewsWire • 07/14/20
Flexion Therapeutics (FLXN) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/08/20